Search or choose
Find the right test or package.
t(4;14)(p16;q32) IGH/ FGFR3
The t(4;14)(p16;q32) IGH/FGFR3 translocation is a chromosomal abnormality that is found in approximately 10% to 15% of multiple myeloma cases. It is the most common translocation in multiple myeloma and is associated with poor prognosis.
DiagnosticsLab test
Know more about this test
The t(4;14)(p16;q32) IGH/FGFR3 translocation is a chromosomal abnormality that is found in approximately 10% to 15% of multiple myeloma cases. It is the most common translocation in multiple myeloma and is associated with poor prognosis.
Understanding t(4;14)(p16;q32) IGH/ FGFR3
The t(4;14)(p16;q32) IGH/FGFR3 translocation is a chromosomal abnormality that is found in approximately 10% to 15% of multiple myeloma cases. It is the most common translocation in multiple myeloma and is associated with poor prognosis.
What does t(4;14)(p16;q32) IGH/ FGFR3 measure?
The t(4;14)(p16;q32) IGH/FGFR3 translocation is a chromosomal abnormality that is found in approximately 10% to 15% of multiple myeloma cases. It is the most common translocation in multiple myeloma and is associated with poor prognosis.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.